Dr Gillian Hendy (left) of Avectas, the Irish cell engineering company, meets Emily Whitehead, who, as a seven-year-old, was the first child patient worldwide to have her cancer successfully treated by Car-T cell therapy, where her own cells were re-engineered to fight her cancer. Ten years on, she was in Dublin to meet companies, oncologists and patient advocates working in the area. Car-T cell therapy this week became available to Irish children with leukaemia. In the background are Emily's parents, Tom and Kari. Photograph: Fennells
World’s first recipient of Car-T cancer therapy is now 17
Emily Whitehead welcomes news Car-T is available to Irish children with leukaemia

Join The Irish Times on WhatsApp and stay up to date
Sign up to the Business Today newsletter for the latest new and commentary in your inbox
Listen to Inside Business podcast for a look at business and economics from an Irish perspective